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Abstract
Background: Selection bias is a concern when designing cluster randomised controlled trials (c-RCT). Despite
addressing potential issues at the design stage, bias cannot always be eradicated from a trial design. The
application of bias analysis presents an important step forward in evaluating whether trial findings are credible. The
aim of this paper is to give an example of the technique to quantify potential selection bias in c-RCTs.
Methods: This analysis uses data from the Primary care Osteoarthritis Screening Trial (POST). The primary aim of this
trial was to test whether screening for anxiety and depression, and providing appropriate care for patients
consulting their GP with osteoarthritis would improve clinical outcomes. Quantitative bias analysis is a seldom-used
technique that can quantify types of bias present in studies. Due to lack of information on the selection probability,
probabilistic bias analysis with a range of triangular distributions was also used, applied at all three follow-up time
points; 3, 6, and 12 months post consultation. A simple bias analysis was also applied to the study.
Results: Worse pain outcomes were observed among intervention participants than control participants (crude
odds ratio at 3, 6, and 12 months: 1.30 (95% CI 1.01, 1.67), 1.39 (1.07, 1.80), and 1.17 (95% CI 0.90, 1.53), respectively).
Probabilistic bias analysis suggested that the observed effect became statistically non-significant if the selection
probability ratio was between 1.2 and 1.4. Selection probability ratios of > 1.8 were needed to mask a statistically
significant benefit of the intervention.
Conclusions: The use of probabilistic bias analysis in this c-RCT suggested that worse outcomes observed in the
intervention arm could plausibly be attributed to selection bias. A very large degree of selection of bias was
needed to mask a beneficial effect of intervention making this interpretation less plausible.
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Background
Cluster randomised controlled trials (c-RCT) are
increasingly being used to evaluate the intended effects
of complex interventions in primary care [1] and other
health and social care settings [2]. The decision to
choose cluster randomisation over individual patient
randomisation is typically justified by the intervention
being directed at the level of the cluster (practitioner,
practice, hospital, etc.), or on the grounds of perceived
risk of experimental contamination, or on cost, compli-
ance, investigator cooperation, and other logistic consid-
erations [3]. While c-RCT designs may offer a solution
to these problems, and sometimes offer additional
advantages (e.g. external validity), they also raise a
number of specific methodological and ethical issues.
Among these issues, vulnerability to selection bias is an
important concern in c-RCT designs where individual
participants are identified and recruited after randomisa-
tion, especially when the person identifying and
recruiting participants is not blinded to allocation and
the process of identification and/or recruitment is open
to interpretation [4].
Prevention of bias is the ideal and a range of strategies
have been proposed to minimise selection bias in the
design and implementation phases of c-RCTs [5, 6]. How-
ever, in instances where these strategies are not, or cannot
be, adopted, or where their success is not assured, it is
important to carefully evaluate the potential role of selec-
tion bias in the interpretation of the trial findings. In the
context of epidemiological studies, quantitative bias
analysis (QBA) has been proposed as an approach to
evaluating the role of bias in published research and an
alternative to the traditional handling of this by qualitative
judgements and educated guesses in the Discussion
sections of articles [7–10]. Quantitative bias analysis
involves quantifying the magnitude, direction, and effect
of bias present in studies [11]. There are three types of
bias that can be adjusted for; misclassification, unmeas-
ured confounders, and selection bias which this paper will
investigate. Selection bias occurs when the intervention
and outcome are both conditioned on subject participa-
tion; a common problem in c-RCTs where subjects are
not individually randomised. If all eligible participants do
not get enrolled into the study and this is related to out-
come and intervention, then any association found from
the analyses conducted on the data with those who did
contribute data will be different to any associations that
would be found when using all eligible subjects [12]. The
motivation for conducting a QBA is to adjust the estimate
for the association between exposure/intervention and
outcome for the presence of selection bias, induced by
conditional participation.
To our knowledge, to date there has been little appli-
cation of QBA to c-RCTs including the specific matter
of how robust the findings are to difference in selection
between intervention and control arms after randomisa-
tion. We conducted a small, non-systematic scoping
review of Cochrane Library full-text papers published
between 2013 and 2016 and reporting original findings
c-RCTs available in the Cochrane Library. We chose
Cochrane due to its broad scope of published trial
papers. We identified a total of 35 trials; 13 commented
on selection bias, of which four discussed its role on
study findings, but none reported any formal quantita-
tive evaluation of its role.
The aim of this paper was to apply quantitative bias
techniques to a c-RCT whose design rendered it vulner-
able to selection bias, in order to evaluate the extent to
which different degrees of selection bias would modify
the estimated effect of intervention and the conclusions
drawn from it.
Methods
Data source
This QBA used data from the Primary care Osteoarth-
ritis Screening Trial (POST) – a pragmatic, cluster
randomised, parallel, two-arm trial in primary care in
which 45 practices were block-randomised 1:1 to inter-
vention or control using a balance algorithm based on
list size, area deprivation and clinical commissioning
group (CCG). When patients consulted for osteoarthritis
during the study period, and an osteoarthritis diagnos-
tic/symptom code was recorded by the general practi-
tioner (GP) in their electronic record, a point-of-care
electronic template was activated which was used to
record screening data, prompt GPs to ask screening
questions and identify those potentially eligible for
inclusion. The intervention was point-of-care anxiety
and depression screening and pain intensity assessment
by the GP. The control was point-of-care pain intensity
assessment by the GP, similarly prompted by an
electronic template installed on all computers in the
control practices but containing only the item on
current pain intensity.
Individual-level patient outcomes were measured by
self-complete postal questionnaires administered to
patients shortly after their consultation and at 3-, 6-, and
12-month follow-up and by medical record review. The
primary outcome of this trial was pain intensity,
measured on a 0–10 scale, with a score of 10 being ‘pain
as bad as it can be’. In the primary analysis of the trial
this outcome was analysed across 12 months post
consultation (i.e. analysis was undertaken across post
consultation, 3, 6, and 12 months) using a hierarchical
linear mixed model with unstructured covariance,
including GP practice (at level 3) and individual partici-
pants (at level 2) as random effect variables (a logistic
mixed model was used for categorical variables), with
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repeated measurements of assessment data per individ-
ual at level 1. A number of pre-specified covariates were
included in the statistical models to help overcome
potential selection and confounding bias.
The trial was approved by an independent Research
Ethics Committee (11/WM/0093), was prospectively
registered (ISRCTN: 40721988), and had a pre-defined
protocol, including statistical analysis plan (available
from the authors on request). The main findings have
been published [13]. The current bias analysis was not
included in that pre-specified statistical analysis plan but
was instead designed after the primary analysis was com-
pleted and the principal trial findings known.
The primary endpoint intention-to-treat analysis found
a significantly higher average pain score over the four
follow-up time points in the intervention group than the
control group (mean difference 0.33, 95% CI 0.05, 0.61;
effect size 0.16: 0.02, 0.29). The largest difference of 0.50
was observed at 6-month follow-up. A similar pattern of
findings was seen for secondary outcomes.
Potential for selection bias
In the POST trial, individual participants were identified
and recruited after randomisation by the treating GP
who was not blinded to allocation – a process in which
the selective exclusion of ineligible participants was
possible. Despite a number of strategies being adopted
to mitigate the risks of selection bias, it was noted that a
lower proportion of potentially eligible patients were
recruited in the intervention arm than in the control
arm (16.5% and 21.5%, respectively) and that interviews
with GPs in the intervention practices suggested that
there might have been ‘selective exclusion of patients at
low risk of poor outcome due to perceived irrelevance
or intrusiveness of anxiety and depression screening
questions in patients with a favourable prognosis or a
tendency to reserve screening questions for patients
expressing emotional cues/concerns’ [13]. The direction
of this selection bias would be capable of producing the
observed finding of worse pain outcomes in the
intervention arm.
Bias analysis
For the purposes of this bias analysis we dichoto-
mised the primary pain intensity outcome measure
into ‘low pain’ (0–5) and ‘high pain’ (6–10) [14, 15].
Quantitative bias analysis has been developed in, and
typically applied to, categorical outcomes. We chose
6-month follow-up as the endpoint of greatest interest
as this was when the largest difference between the
two arms of the trial was observed in the primary
analysis. We also repeated the analysis for 3- and 12-
month follow-up time points.
Probabilistic bias analysis
To explore the impact of a range of selection probabil-
ities (the probability of being recruited into a trial based
on intervention and outcome status) on the treatment
effect estimate we undertook probabilistic bias analysis
(PBA). This technique requires choosing a distribution
from which the samples of the selection odds ratios
(ORs) will be drawn. A ‘selection odds ratio’ is calculated
from the selection probabilities and used to correct the
observed treatment effect OR. We chose the triangular
distribution (one of three available and applicable distri-
butions at the time of analysis) as the closest to a normal
distribution, and given that there was no evidence to
suggest that the data was not normally distributed. The
density function for the triangular distribution is given
as Equation 1:
P xð Þ ¼
2 x−að Þ
b−að Þ c−að Þ f or a ≤ x ≤ c
2 b−xð Þ
b−að Þ b−cð Þ f or c ≤ x ≤ bÞ
8
>><
>>:
ð1Þ
where x ∈ [a, b] lies between the limits of the
distribution, and c ∈ [a, b] is the mode. The triangular
distribution is commonly written as:
Triangular a; b; cð Þ
We repeated our analyses using a wide (range = 0.8) or
narrow (range = 0.4) triangular distribution and each
with a mode ranging from 0.9 to 2.0. The distributions
thus included examples with greater or lesser
uncertainty and that represented more extreme and less
extreme (including no) selection bias when compared
with the scenario described in the simple bias analysis.
Six of the triangular distributions are shown in Fig. 1.
The analyses were applied first to outcome at 6
months and then to outcome at 3 and 12 months.
Simple bias analysis
Using methods described by Greenland (1996) and Lash
et al. (2009), we undertook a simple bias analysis in
which we hypothesised different selection probabilities
among potentially eligible patients in intervention and
control arms and with respect to outcome status at 6
months. Specifically, we calculated the bias-corrected
OR for treatment effect at 6 months under the assump-
tion that the selection probability among potentially
eligible patients with ‘high pain’ in the intervention arm
was the same as in the control arm. The direction of
selection bias in this scenario, therefore, accords with
the evidence from qualitative interviews with practi-
tioners. However, it is likely to be extreme, since GPs are
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imperfect judges of the future pain outcomes of patients
[16] and selection of patients perfectly related to
outcome is implausible.
All analysis was completed using R studio version
0.99.902 through Windows.
Results
Observed results
Table 1 shows the categorised data from the POST trial
to be used in the analyses. From the total numbers it
can be seen that there was almost double the number of
patients available for analysis in the control arm than
the intervention for each follow-up time – due to a
larger number of allocated practices and larger average
size of practices (leading to the higher numbers of
potentially eligible patients in the control arm (4238)
than the intervention arm (3041)) as well as a higher
selection of patients mailed a questionnaire in the
control arm (1339 (31.6%) in the control arm versus 703
(23.1%) in the intervention arm).
At 3 months 383 (12.6%) intervention participants of
the 3041 who were initially eligible to participate were
available to analyse, compared with 701 (16.5%) in the
control arm. This pattern was consistent at the 6- and
12-month follow-up (12.3% and 12.1% for the interven-
tion and 16.0% and 15.2% for the control arm, respect-
ively). Worse pain outcomes were observed in the
intervention arm with the observed crude OR (95% CI
simulation) at 3, 6, and 12 months: 1.30 (1.01, 1.67), 1.39
(1.07, 1.80), and 1.17 (0.90, 1.53), respectively.
Probabilistic bias analysis
The results of the probabilistic bias analyses for the out-
come at each of the time points and based on a triangu-
lar distribution with either a relatively narrow (0.4) or
wide (0.8) distribution can be seen in Fig. 2.
As expected, as the selection OR increased above 1, the
bias-corrected OR for the pain outcome reduced for all
follow-up time points. The finding from simple bias ana-
lysis – a bias-corrected OR of 0.91 at 6 months when the
selection OR is 1.52 – is now seen in the context of a range
of selection ORs. When the selection OR was roughly equal
to 1.4 the resulting OR was 1 at 3- and 6-month follow-up,
suggesting that the direction of the selection bias that we
Fig. 1 A sample of three triangular distributions sampled from using probabilistic bias analysis (PBA)
Table 1 New data from the categorised trial outcome for control and intervention arms for each follow-up time point
Follow-up time 3 months 6 months 12 months
Intervention Control Intervention Control Intervention Control
High pain 162 253 159 236 136 215
Low pain 221 448 215 444 232 429
Total 383 701 374 680 368 644
Potentially eligible before recruitment 3041 4238 3041 4238 3041 4238
Crude OR for treatment effect (95% CI) 1.30 (1.01, 1.67) 1.39 (1.07, 1.80) 1.17 (0.90, 1.53)
CI confidence interval, OR odds ratio
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Fig. 2 Results of the probabilistic bias analysis (PBA) conducted at each follow-up time point
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consider to be highly plausible (i.e. upward of 1 and to-
wards 1.5) would show that there was no difference
between intervention and control treatments.
With the larger range of triangular distribution the
simulation interval around the adjusted OR was wider,
but the overall trend towards 1 was unchanged. This
trend appears to begin to level out as it nears an
adjusted OR of 0.5; however, the largest value used in
this analysis was 2.0.
Simple bias analysis
As indicated previously, the selection probability for the
intervention arm was 0.123 and 0.160 for the control arm
at 6-month follow-up. Selection probability combines ini-
tial enrolment into the trial and retention to 6 months. If
this was nondifferential with respect to the outcome at 6
months, there would be no selection bias and the bias-
corrected OR equals the crude OR (Table 2A).
This is contrasted with the bias-corrected OR under
the extreme assumption that selection was differential
with respect to outcome at 6 months such that selective
under-recruitment in the intervention arm affected only
those with ‘low pain’ (i.e. a favourable outcome). In this
scenario we assumed that the total numbers of patients
recruited to the intervention and control arms remained
as observed, as did the marginal selection probabilities.
The selection probability of the ‘high pain’ group in the
intervention arm was fixed at 0.160 (to be equal to con-
trol arm). The ‘low pain’ selection probability is, there-
fore, 0.105. This scenario yields a selection OR of 1.52
and a bias-corrected OR of 0.91.
Discussion
It is plausible that a selection (bias) OR of 1.2 to 1.4 to-
wards higher-risk patient recruitment to the intervention
compared to the control arm occurred within the POST
Table 2 Simple bias analysis applied to 6-month pain outcome; (A) selection probabilities within treatment arm are assumed to be
nondifferential with respect to outcome at 6 months (i.e. no selection bias); (B) selection probabilities within treatment arm are
differential with respect to outcome at 6 months, such that the selection probability of patients with high pain is the same in
intervention and control arms (i.e. selection bias producing worse outcomes in intervention arm)
(A) Intervention (=1) Control (= 0)
Outcome at 6 months = high pain (= A) nA1 = 159 NA0 = 236
SA1 = 0.123 SA0 = 0.160
NA1 = 1293 NA0 = 1471
Outcome at 6 months = low pain (= B) NB1 = 215 nB0 = 444
SB1 = 0.123 SB0 = 0.160
NB1 = 1748 NB0 = 2767
Total potentially eligible N1 = 3041 N0 = 4238
Total actually recruited and retained to 6 months n1 = 374 n0 = 680
Overall selection probability within treatment arm S1 = 374/3041 = 0.123 S0 = 680/4238 = 0.160
Selection odds ratio (OR) SA1SB0/SA0SB1 = (0.123 × 0.160)/(0.160 × 0.123) = 1
Crude cOR for treatment effect nA1nB0/nA0nB1 = (159 × 444)/(236 × 215) = 1.39
(B) Intervention (= 1) Control (= 0)
Outcome at 6 months = high pain (= A) nA1 = 159 NA0 = 236
SA1 = 0.160 SA0 = 0.160
NA1 = 991 NA0 = 1471
Outcome at 6 months = low pain (= B) NB1 = 215 nB0 = 444
SB1 = 0.105 SB0 = 0.160
NB1 = 2050 NB0 = 2767
Total potentially eligible N1 = 3041 N0 = 4238
Total actually recruited and retained to 6 months n1 = 374 n0 = 680
Overall selection probability within treatment arm S1 = 374/3041 = 0.123 S0 = 680/4238 = 0.160
Selection OR SA1SB0/SA0SB1 = (0.160 × 0.160)/(0.160 × 0.105) = 1.52
Crude OR for treatment effect nA1nB0/nA0nB1 = (159 × 444)/(236 × 215) = 1.39
Bias-corrected OR for treatment effect Crude OR/Selection OR = 1.39/1.52 = 0.91
Figures in italics in cells are unobserved; OR odds ratio; nij number of participants in that cell, Sij cell selection probability; Nij total participants in each cell if all
eligible patients had been recruited
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trial. The imbalance in recruitment between the two
arms could have introduced selection bias; however, it
could also be down to chance. There could have been
selection bias present in this study even if the number of
patients in each arm had been the same.
To our knowledge the applications of QBA in the
existing academic literature are few. The studies that
have applied this methodology are cohort or case-
control, and involve longitudinal data. In a study investi-
gating the association between smoking and the devel-
opment of multiple types of cancer, QBA adjusting for
misclassification of smoking status was conducted. The
results showed that the higher relative risks (RR) were
consistently lower than the misclassification-adjusted
estimates [17]. Another study investigated misclassifica-
tion in a case-control setting. They looked into the asso-
ciation dietary patterns on the increase in risk of
prostate cancer. After adjustment for misclassification
they found slight differences in the ORs in that they
were slightly higher than those observed, and that the
simulation limits were nearly double the observed [18].
A recent paper involving the use of QBA adjusted for
unmeasured confounding. This study looked into the
effect an unmeasured confounder had on the association
between firearm availability and suicide. Their study
showed that the unmeasured confounder would need to
be as strong a risk factor as the most potent currently
known, such as psychopathology, and socio-economic
factors to affect the observed results [19]. However, the
authors did go on to suggest that quantifying the extent
to which it may change observed results helps to
strengthen the results themselves [19].
The results of previous studies, and this report, show
the value of conducting a QBA for most kinds of bias
present in studies and trials. By adjusting for bias
researchers can have more confidence in the results that
they are reporting rather than resorting to a theoretical
comment in the Discussion section, and it can also help
to strengthen the results reported in the study, thereby
affecting policies which are built on those reported
results [19]. There are other methods for quantifying
bias in c-RCTs, notably by using propensity score (PS)
methodology when analysing c-RCT data as a cohort
[20–22]. Propensity scores are used to adjust the
comparison between intervention and control for base-
line imbalance in observed and unobserved patient-level
characteristics. It is unclear whether QBA is superior to
the PS approach. However, approaches that use baseline
imbalances could be used to help choose plausible bias
scenarios and parameters for QBA.
The main strength of this study is that it is the first
that has applied QBA to a c-RCT, thereby providing a
framework with which researchers can apply this
analysis to c-RCTs where selection bias may be of
concern. Another advantage of bias analysis is the flexi-
bility that a researcher has when deciding the direction
of the selection bias. In this example we hypothesised,
based on observed evidence, that those with low pain/
good prognosis were less likely to be recruited into the
intervention arm; however, the converse is also plausible,
i.e those with high pain were less likely to be recruited
to the intervention arm. The bias parameters can be
altered to reflect this line of thought.
However, there are a few limitations. The first is that
the outcome, pain, had to be transformed into binary for
the analysis. This results in a loss of information [23],
and potentially an underestimation in the variability of
results between the two treatment groups. Secondly, due
to the nature of QBA the results could not be adjusted
for anything other than the selection bias, hence the
resulting ORs are not adjusted for common patient
demographics such as age and gender.
Another main limitation to the approach of our evalu-
ation is that no ‘true’ selection probabilities could be
calculated as no follow-up questionnaires were sent to
those who did not participate. This step, although useful
in theoretical platforms, is perhaps less practically imple-
mented in cases such as clinical trials where recruitment
is often difficult. The source of the selection bias in this
trial can only be hypothetical as voiced by the
researchers and it would be impossible to find out if GPs
in the control practices were more inclined to recruit
different types of patients than those in the intervention
due to the nature of the intervention treatment. Another
limitation of this study surrounds the formula developed
for simple bias analysis. It does not differentiate between
data from patients not enrolled in the trial, and those
who were lost to follow-up. We were unable to conclude
the origin of any selection bias present in this study,
whether down to the imbalance in recruitment or to
genuine selection bias on the part of the recruiting GPs.
Quantitative bias analysis is a useful tool for insight
into the sources of bias present in a trial; however, PBA
as used in this study is largely subjective and will be
prone to the same counter arguments as that of Bayesian
analysis. There are many similarities between PBA and
Bayesian methodology, as MacLehose and Gustafson
have shown. In broad terms PBA is simply a Bayesian
algorithm where the observed data is not updated with
each iteration. In both cases one begins with a prior
distribution from which iterative samples are taken. The
main difference comes from the conditional posterior
distribution, where in the Bayesian approach the result
depends on the samples taken from the previous iter-
ation of sampling, in PBA the values of the sampled bias
parameters are limited to the observed data, hence
certain values of bias parameters may be possible in
Bayesian platforms, but would be impossible in PBA
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[24]. However, despite their subtle differences, in some
cases PBA can be seen as a Bayesian analysis with a
uniform prior [24].
An important area for future research would be to
investigate and develop the use of QBA in trial settings,
as all existing academic literature has been applied to
observational studies. it is acknowledged that in some
cases applying QBA to the results of studies results in
no difference in the results; however, there have been
examples where applying this methodology has provided
insights into the effect of bias on the observed results
[17, 18].
The POST trial presents a useful case example for
illustrating the possible impact that selection bias has on
the conclusions of a trial. Using this example we have
shown how bias analysis can add to interpretation of
results of a c-RCT and planning to routinely obtain
empirical data from people excluded from c-RCTs would
enhance the utility of bias analysis.
Conclusion
There was some evidence to suggest that if the assump-
tions underlying our range of selection bias scenarios were
true then selection bias could have affected the results of
the POST trial. Rather than being harmful it would appear
more likely that there was no difference between the inter-
vention treatment and the control. Evidence of extreme
levels of selection of mild patients into the intervention
group would be needed to judge that outcomes were
actually better in the intervention group than in the
control. Applying QBA to a trial provides researchers with
more confidence and insight into the conclusions that
were produced and should be incorporated into the
analysis plan at the design stages of the trial.
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